biotechnology

2 articles tagged "biotechnology"

Fintech

Evommune Launches Initial Public Offering for Stock Sale

Evommune, Inc. announced its initial public offering, aiming to sell 9.375 million shares priced between $15 and $17 each. Trading is expected to commence soon on the NYSE under the symbol 'EVMN.'

29 Oct 2025

Fintech

Spyre Therapeutics Raises $275 Million in Public Offering to Advance IBD Treatment Pipeline

Spyre Therapeutics has priced a $275 million public offering of 14.86 million shares at $18.50 each to fund development of IBD treatments. The Waltham-based biotech company focuses on extended half-life antibodies targeting α4β7, TL1A, and IL-23 for inflammatory conditions. The offering is expected to close October 15, 2025, with major investment banks including Jefferies and TD Securities managing the deal.

13 Oct 2025